Navigation Links
BUMC provost, BUSM dean, to be honored at world's largest meeting of oncology professionals
Date:5/29/2008

Boston, MA--Weston resident Karen H. Antman, MD, provost of Boston University Medical Campus and dean of Boston University School of Medicine, will be honored with the Distinguished Service Award for Scientific Leadership by the American Society of Clinical Oncology (ASCO) at their annual meeting in Chicago this weekend. Antman, an internationally renowned expert in the field of breast cancer, is widely recognized for her development of a standard treatment regimen for sarcoma.

Each year through the Special Awards Program, ASCO identifies those individuals whose personal commitment to furthering the progress against cancer has led to tremendous advances in the field. Research scientists and others dedicated to improving the lives of people living with cancer are nominated to receive ASCOs highest, most prestigious awards. The collective efforts of this years recipients are credited with important strides in bettering the care of children and older adults with cancer in addition to impacting cancer prevention and developing new treatment modalities.

It is our honor to bestow upon Dr. Antman ASCOs highest award of achievement, said Gabriel N. Hortobagyi, MD, FACP, ASCO Past President and Chair of the Special Awards Committee.

Antman assumed the positions of Provost of the Medical Campus and Dean of Boston University School of Medicine on May 1, 2005. She came to Boston University from the National Cancer Institute of the National Institutes of Health (NIH) where she served as Deputy Director for Translational and Clinical sciences in 2004 and 2005. Previously, she spent more than 10 years on the faculty of Columbia University College of Physicians and Surgeons, where she was Wu Professor of Medicine and Pharmacology and Director of the Herbert Irving Comprehensive Cancer Center, a National Cancer Institute-designated Cancer Center.

Antman was voted Senior Faculty Teacher of the Year by medical residents at Columbia in 1993. She also served on the faculty of Harvard Medical School from 1979 to 1993, and had hospital appointments at Brigham and Womens Hospital and Dana-Farber Cancer Institute in Boston and Presbyterian Hospital in New York.

She has written extensively about impediments to clinical research on cancer, and she has testified before Congress on the need for federal research dollars to support cancer research with articles in the medical literature. She has written more than 300 journal papers and edited five textbooks and monographs, many with multiple editions.

Antman has served as President of the American Society of Clinical Oncology, the American Association for Cancer Research, and the American Society for Blood and Marrow Transplantation. She served for seven years as an associate editor of the New England Journal of Medicine and currently serves on the international editorial board of the Lancet and several other major medical journals. She currently sits on the Council of the NIHs Fogarty International Center.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Related medicine news :

1. Five Heart Heroines Honored With Cheerios Sisters Saving Hearts(TM) Grants
2. Prof. Dr. George Gettinby Honored With Dieter Lutticken Award
3. Roche Vice President Senich Honored at EWNJ Salute to Policy Makers
4. American Lung Association Founder Honored With New U.S. Postage Stamp
5. Roches Vidal Honored as 2008 HBA Rising Star
6. GSKs Ernestine Harris Honored as Industry Rising Star by Healthcare Businesswomens Association
7. 2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression
8. Celebrity Cancer Advocates to be Honored at Washington, D.C. Benefit
9. Houston Northwest Medical Center Caregiver Honored by Tenet Healthcare
10. Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate
11. Dr. Mei honored by mental health research charity for schizophrenia studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... They are musicians and librarians, fashion ... brothers and fathers, from New England and around the nation. What do they have ... brought together in a beautiful and compelling new photographic exhibit debuting Friday, December 9 ...
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... offering insurance and financial planning services to families and business owners in the ... funds on behalf of the Dallas Fallen Officer Foundation. , Established in 2009 ...
(Date:12/7/2016)... ... 07, 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... Voice of America, declared on her radio program in November 2016 the need to ... these bullies attack leaders in corporate America, they are trying to take advantage of ...
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (IFW) Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 ... of three acupuncturists to help patients realize their family building goals. Acupuncture ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7,2016  Based on ... delivery industry, Frost & Sullivan recognizes Nemaura ... & Sullivan Award for Enabling Technology Leadership. ... the loopholes in traditional drug delivery technologies, ... liquid microneedle-based drug delivery technologies, Memspatch and ...
(Date:12/7/2016)... , December 7, 2016 According ... Research titled , Global Market Study on Multiplex Detection Immunoassay: ... , the global multiplex detection immunoassay market is expected to ... 2016-2024. ... ,      ...
(Date:12/6/2016)... Mass. , Dec. 6, 2016  Alopexx Oncology, ... DI-Leu16-IL2, a recombinant antibody fusion protein (immunocytokine) composed of ... recognizes the same target on B cells as Rituxan ... cytokine components but is also involved in tumor targeting, ... anti-cancer vaccine effect. The results of the study (abstract ...
Breaking Medicine Technology: